NeuroBionics develops hair-thin, flexible bioelectronic fibers that can record and stimulate neural activity, deliver drugs, and ablate tissue through an endovascular approach. This technology enables minimally invasive deep brain stimulation, expanding access to treatment for conditions such as Parkinson's disease, epilepsy, and depression.
Funding
$5.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
DFFounders
Product
Problem
Current deep brain stimulation (DBS) techniques require invasive open brain surgery, creating barriers to access and increasing risks for patients with neurological disorders like Parkinson's disease, epilepsy, and depression. Existing neural interfaces often lack the flexibility and biocompatibility needed for seamless integration with neural tissue.
Solution
NeuroBionics develops minimally invasive bioelectronic fibers for neural interfacing, enabling endovascular delivery of deep brain stimulation. These hair-thin, flexible fibers can record and stimulate neural activity, deliver drugs, and ablate tissue, offering a less invasive alternative to traditional DBS. The technology aims to expand access to neuromodulation therapies by delivering targeted brain stimulation from inside a blood vessel, eliminating the need for open brain surgery. The multifunctional fiber technology also supports electrical, optical, and chemical recording and stimulation in a single integrated device, accelerating neuroscience research.
Target Audience
The primary target audience includes patients with neurological disorders requiring deep brain stimulation, neurosurgeons, neurologists, and neuroscience researchers.
Features
- Hair-thin, flexible bioelectronic fibers for seamless integration with neural tissue
- Endovascular delivery system for minimally invasive deep brain stimulation
- Multifunctional fibers capable of electrical, optical, and chemical recording and stimulation
- Targeted drug delivery and tissue ablation capabilities
- Compatibility with existing deep brain stimulation protocols
- Integrated device design for streamlined neuroscience research